MGF

MGF (mechano growth factor) is an IGF-1 splice variant studied for satellite-cell activation, muscle repair, and tissue regeneration, with the practical dosing discussion remaining preclinical.


Profile · 01

Overview

MGF, or mechano growth factor, is a splice variant of IGF-1 that is naturally upregulated in response to mechanical stress and tissue damage. The source describes it as a more localized tissue-repair signal than full-length systemic IGF-1.

Human clinical data are absent, so the page is necessarily built from cell and animal studies plus practical research-culture dosing conventions. This page summarizes the once-daily subcutaneous titration path described in the source markdown.

At a Glance

Goal
Support tissue-repair and regenerative signaling through satellite-cell and local growth-factor pathways
Categories
Tissue RepairMuscle RecoveryRegenerationGrowth Factor Signaling
Synergistic
PEG-MGF · IGF-1 LR3 · BPC-157

Profile · 02

Protocol

Suggested once-daily titration approach with weekly increases toward the target range.

Reconstitute
Add 3.0 mL bacteriostatic water to a 5 mg vial for about 1.67 mg/mL concentration
Typical daily range
100-300 mcg once daily
Start
100 mcg daily for Week 1
Target
300 mcg daily by Week 5
Frequency
Once daily (subcutaneous)
Cycle Length
8-12 weeks with optional extension to 16 weeks
Timing
Any consistent time; many pair it with the post-exercise window
Route
Subcutaneous
Cycle
8-12 weeks on, 4 weeks off

Inject once daily subcutaneously using a dilution that keeps dose measurements above very tiny volumes. The source notes that native MGF has a short half-life and that all practical dosing remains extrapolated from preclinical work rather than human trials.

Dose progression

Week 1
100 mcg (0.10 mg) · 6 units (0.06 mL)
Week 2
150 mcg (0.15 mg) · 9 units (0.09 mL)
Week 3
200 mcg (0.20 mg) · 12 units (0.12 mL)
Week 4
250 mcg (0.25 mg) · 15 units (0.15 mL)
Weeks 5-8+
300 mcg (0.30 mg) · 18 units (0.18 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.


Science · 01

How MGF works.

MGF is described as a mechanically induced IGF-1 splice variant that helps activate quiescent satellite cells and stimulate myoblast proliferation. This makes it conceptually distinct from simply increasing circulating IGF-1 levels.

The source also cites preclinical work involving bone repair and neurogenesis. However, all efficacy claims remain grounded in cell culture and animal studies rather than human clinical protocols.


Science · 02

Effects

Observations from clinical or preclinical literature.

Preclinical work suggests satellite-cell activation and support for muscle-repair signaling
Animal and cell studies also discuss bone and neural regenerative effects
May appeal in research settings focused on post-exercise or injury-repair biology
Human efficacy and safety data are absent
Mild injection-site irritation may occur
Long-term systemic effects remain unknown

Science · 03

Caution

Avoid in active cancer or significant cancer history because growth-factor signaling can be growth-promoting
Not recommended during pregnancy or breastfeeding because safety data is absent
Use caution when combining with other IGF-1 or GH-axis compounds
This is a preclinical peptide with no formal human trial base for the protocol described here

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.


Lifestyle · 01

CoFactors

Protein intake
Provides substrate for the tissue-repair pathways MGF is meant to support.
Zinc
Supports wound healing and tissue repair.
Vitamin D
Relevant to musculoskeletal and bone-health signaling.
Magnesium
Supports enzymatic recovery and neuromuscular function.

Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Pair with appropriate resistance training or rehab work to reinforce the mechanical-signal context
Maintain adequate protein intake and a recovery-supportive diet
Prioritize sleep and overall recovery because regeneration is recovery-limited
Avoid overtraining if the goal is repair rather than simply chasing more stimulus

Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Strength and functional performance - track changes in load tolerance or output
  2. Pain and range of motion - especially useful in repair-focused contexts
  3. Body composition - monitor lean-mass and recovery-related changes
  4. Injection-site reactions - note redness, swelling, or discomfort

Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

IGF-1
Provides broader growth-factor context during use.
CBC (Complete Blood Count)
General baseline and follow-up monitoring.
CMP (Comprehensive Metabolic Panel)
Assesses liver and kidney function during the protocol.
CRP (C-Reactive Protein)
Useful broad inflammatory context marker.

Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 5 mg each
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe

Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mcg/mL
Volume per dose
0mL

Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.

Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry fully
Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
Rotate sites across the abdomen, thighs, and upper arms to reduce local irritation
Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.


Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.

Reference · 01

Notes

Use a new sterile insulin syringe for each injection and dispose of it safely
MGF has a short half-life; do not assume it behaves like PEG-MGF
Document dose, site rotation, and training context for consistency
All practical dosing discussion here is extrapolated from preclinical work rather than human trials
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.

Reference · 02

References

  1. PLOS ONE
    IGF-1 Ec / mechano growth factor splice-variant characterization.
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076133
  2. Journal of Molecular Endocrinology
    IGF-I splice variants in tendon repair.
    https://pubmed.ncbi.nlm.nih.gov/12816994/
  3. Experimental Cell Research
    MGF E-peptide activation of human muscle satellite cells.
    https://pubmed.ncbi.nlm.nih.gov/17950277/
  4. Molecular Brain
    MGF-related neurogenesis work in aging mouse brain.
    https://link.springer.com/article/10.1186/s13041-017-0304-0
On this page